Bill is an accomplished medical device executive with significant early-stage start-up and growth companies experience. Bill began his career with CR Bard in the late 1980s as a sales professional and rose to the position of VP Sales. Upon his departure he was part of initially starting PHX, the e-commerce company for Premier (GPO), merging with Medibuy.com and eventually purchased by GHX, the eCommerce engine for Healthcare today. Bill then transitioned over to helping to start Venetec international growing revenue from $1M to $36M over 5 years, and then was instrumental in selling the company for $168M in 2006.

Bill then joined Access Scientific and was engaged in strategic partner formation and capital acquisition. Completing a pre-FDA non-significant risk trail, Bill developed and implemented the go-to-market field strategy leading Access Scientific to be purchased by Smiths Medical.

He then joined Vascular Pathways managing the commercialization efforts to bring three individual vascular access devices to market. Engaged in-field testing and product development, FDA submission, and 510(k) approval, sales and clinical force inception and success expansion, Bill turned the company around leading to a successful exit of $105M and a 4x return for key investors.

Michael Anstett is an accomplished clinician, corporate executive, armed services veteran, and entrepreneur. Michael’s clinical career spans nearly 30 years.

Starting his career as US Army Combat Medic, he went on to receive his nursing degree 1994 and became a board-certified in infusion therapy and vascular access. He was the nurse manager over vascular access at a level one trauma center in Tampa, FL.

In 2005, Michael founded his private practice Professional Infusion Consultants, Inc. which later sold in 2012. He then served as the Director of Clinical Operations at Medical Components, Inc. where he supported all aspects of the company’s business including R&D of new products, business development, clinical education, regulatory.

Michael is named on multiple medical device patents. He is a member and strong supporter of the Association for Vascular Access (AVA) and has lectured at both local and national AVA conventions. Michael is published in JAVA 2003 and won clinical manuscript for that year.

He is the Founder of SkyDance Vascular, Inc. and the inventor of the Osprey vascular access device.

John’s career spans more than 25 years in engineering management, technology design, and research and development. After earning a Master’s Degree in Engineering Management from Stanford University, John spent his early career in Silicon Valley.

John’s is currently the Chief Technology Officer with SkyDance Vascular leading R&D and design efforts on the groundbreaking Osprey catheters, the first and only through-the-needle catheter delivery system..

Prior to joining SkyDance John was founder and CEO of Lumitec, a leader in the design, and manufacture of specialized LED lighting devices for marine, industrial, and law enforcement applications. Recognized for 8 consecutive years on Inc. Magazines prestigious “Fastest Growing Private Companies” list, Lumitec has been a frequent winner of industry Innovation Awards in the US and Europe. In 2018 John was recognized in 2018 by Florida Governor Rick Scott as an “Entrepreneur of Distinction” for his success in building a technology company with local manufacturing and global distribution. John sold Lumitec to the Truck-Light corporation in 2019, which continues to value and nurture Lumitec’s culture of innovation and growth.

Prior to starting Lumitec, John serviced in a variety of management roles at various technology hardware and software companies in Palo Alto, CA and Austin, TX.

Thomas is a senior manufacturing executive with over 25 years of experience, primarily in the medical device industry. Thomas has held various positions of increasing responsibility, including the Director of Engineering at Baxter Healthcare, managing both the manufacturing engineering and the R&D engineering activities, as well as the Senior Vice President of Manufacturing for Covidien’s International Division, managing 20 manufacturing facilities with 8,500 people located throughout Europe, Asia, Africa, and Latin America.

Thomas is a strategic and operational leader with a highly successful career, having played a key role in growing revenues, increasing operational efficiencies, reducing costs, and bringing new products to the market. His training in both Lean manufacturing and Six Sigma has aided his success in creating World Class Manufacturing environments for several businesses.

Thomas has a strong attraction to new or proprietary medical device start-ups and the process of building and leading a cohesive, high-performance operations team to deliver profitable and strong growth results year after year.

Thomas graduated with a Chemical Engineering degree from Rutgers University where he played 4 years of Varsity Wrestling and 1 year of Varsity Tennis. He also received an MBA from Pepperdine University.

Scott has over 25 years of experience in the global medical device industry with a wealth of experience in global regulator and quality control systems. Most recently, Scott served as the Sr. VP of Regulatory & Quality at Vestagen Protective Technologies, Inc. Prior to that Scott was the Dir. of Regulatory & Quality Systems for WilMarc Medical and VP of Regulatory Affairs & Quality Assurance of Vascular Pathways, Inc. (VPI), leading to their FDA clearances of AccuCath BC and AccuCath EDC IV Catheters, as well as obtaining both organizations EN ISO 13845 and European Union (EU) Medical Device Directive (MDD) Annex II Certifications.

Scott has held multiple leadership positions in regulatory affairs and quality assurance, while throughout his career as both a consultant or within organizations, he has written or managed staff involved with obtaining market clearances, approvals, and/or registrations for hundreds of medical devices globally. Additionally, Scott worked with the Boards of Companies and Executive/Senior Leadership to develop and maintain strategies ensuring compliance with appropriate global regulations (e.g., FDA, Health Canada, EU MDD, Australia TGA, Japan MHLW-PMDA, etc.,). Scott is RAC (US) and ASQ (CQA & CHA) certified, and has served as the EU MDD Management Representative for many of the companies while leading their efforts in obtaining the necessary certifications to CE Mark their devices.

Dave has more than 30 years of diversified business experience. His background includes working with large, small and start-up companies. He is skilled at developing and executing successful growth strategies, leading forward-looking change management initiatives, identifying and seizing untapped market opportunities and driving both organic and M&A-based expansions.

Dave is a Co-Founder of SkyDance Vascular Inc., co-Founder and President of Verum TCS, a medical device company focused on Vascular Access, and a Founder and Member of SWSA Medical Ventures, a medical device engineering firm focused on improving and inventing innovative solutions to challenges facing the medical community.

Additionally, Dave has worked as the President of Fort Knox Inc. and both the President, Vice President and Chief Financial Officer for Associated Retail Stores, Treasurer and Vice President of Associated Food Stores, and was recruited to be a member of the turnaround team at Clover Club Inc.

His education includes a BS from Weber State University and a Master’s Degree in Business Administration from Utah State University. Dave has served on the boards of the Cancer Wellness House, SUU College of Business and the Utah Heart Association. He was named Humanitarian of the Year by the Muscular dystrophy Association in 2011. Dave is dedicated to education and has been an Adjunct Professor at Weber State University and Utah Valley University where he has taught various technical business courses.

Sharon is a career medical device executive with over 30 years of success across multiple therapeutic areas and geographies. Key achievements in international expansion, business development, strategic repositioning and turnaround, and bringing new technologies through the development process and into commercialization. Broad functional expertise and proven leadership capabilities. Experience: Operating Partner; Altamont Capital, Group Vice President; CR Bard, Vice President; Baxter Healthcare

David is a performance-oriented executive with over 30 years of developing successful strategies, driving profits, and increasing market share. Exceptional strategic and tactical ability to unlock the value of a company and leverage it through the correct fundraising mechanisms, proper messaging and branding, and optimal go-to-market strategy. Experience: President and COO; SkyDance Systems, Executive Roles – Cisco, Avaya, Siemens, and Sony.

David is also the founder and CEO of Thasis, LLC which is advising SkyDance. Thasis is a results-oriented consulting and marketing agency with C-level executives who each has over 25+ years’ experience ranging from large companies to startups. Thasis works with growth-oriented companies and corporate divisions to develop or refine strategy, capitalize, brand, promote, and accelerate go-to-market results.